UNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY’s current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases.
MapLight Therapeutics
3 followers
Thermo Fisher Scientific
286 followers
Gilead Sciences
214 followers
Regeneron
183 followers
BioMarin Pharmaceutical
59 followers
Idexx Laboratories
24 followers
Avantor
20 followers
Galatea Bio
13 followers
Kemin Industries
6 followers
Stemline Therapeutics
4 followers
Akebia Therapeutics
4 followers
Precision For Medicine
3 followers